Alternative Funding Models – Thriving or Surviving Through Investment Disruption

May 28, 2020 2:00PM—3:00PM




COVID-19 has changed our world. For growing life science innovation companies, the same old status quo with investors may not work in the short-term. On Thursday, May 28 at 2:00 Southeast Life Sciences virtually sits down with leaders across the spectrum who work with dozens of companies like yours to help us navigate and learn new survival skills using alternative funding sources and operational hacks. Now is the time to learn and investigate resources out there that might provide a boost, or even a lifeline, in these challenging times. 

Bob Creedan, Managing Director
UVA LVG Seed Fund and New Ventures
Vivian Doelling, Vice President, Investments North Carolina Biotechnology Center
Stephanie Fertig, SBIR Project Manager
National Institute of Neurological Disorders & Stroke (NINDS) at NIH
Matt Hughes, Managing Director
Allele Capital Partners 
Russell Allen (Moderator)
President & CEO, Georgia Research Alliance